Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654756 · ClinicalTrials.gov registry record
Risk of Chronic Kidney Disease Progression
A clinical trial, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- 623
- Enrollment target
NCT02654756 is a clinical trial that has completed, run by Winthrop University Hospital. The registered enrollment target is 623 participants.
The verdict
NCT02654756 has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- 623 participants
- Enrollment target
Study Summary
While there are proven therapies that slow CKD progression, these therapies can at times be harmful and costly. The ability to accurately predict the risk of CKD progression to ESRD would be extremely valuable. The short term versus lifetime risk of CKD progression should be taken into account when making risk based clinical decisions. In a representative CKD practice, the investigators compared the short term and lifetime risk assessment in our stage 3 CKD patients to determine whether decisions based on a short term risk assessment would underestimate the lifetime risk of CKD progression. The investigators also applied the short term risk assessment to our stage 4 CKD patients to determine the frequency with which ESRD risk may be overestimated in CKD stage 4.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 623 participants |
| Start Date | 2013-05 |
| Est. Completion | 2018-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02654756
The ClinicalTrials.gov registry entry for NCT02654756 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 623 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02654756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02654756 about?
NCT02654756 is a clinical study titled "Risk of Chronic Kidney Disease Progression". While there are proven therapies that slow CKD progression, these therapies can at times be harmful and costly. The ability to accurately predict the risk of CKD progression to ESRD would be extremely valuable. The short term versus lifetime risk of CKD progression should be taken into account when ...
What is the current status of trial NCT02654756?
This trial is currently completed. The enrollment target is 623 participants. The study started on 2013-05. Estimated completion is 2018-11.
Who is sponsoring clinical trial NCT02654756?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.